Diagnósticos da América : EBITDA up 28% and net income positive, with leverage and free cash flow significantly improved

About this update from Diagnosticos Da America S.a.

EBITDA rose 28% year-over-year (Current Scope) with margin expansion and improved efficiency, while net income turned positive at R$9 million. Leverage declined to 2.99x, and free cash flow improved by R$101 million, reflecting disciplined capital allocation and operational gains.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Diagnosticos Da America S.a.